|
1
|
Fang M, Zhao YP, Zhou FG, Lu LG, Qi P,
Wang H, Zhou K, Sun SH, Chen CY and Gao CF: N-glycan based models
improve diagnostic efficacies in hepatitis B virus-related
hepatocellular carcinoma. Int J Cancer. 127:148–159. 2010.
View Article : Google Scholar
|
|
2
|
Pang RW, Joh JW, Johnson PJ, Monden M,
Pawlik TM and Poon RT: Biology of hepatocellular carcinoma. Ann
Surg Oncol. 15:962–971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shao Q, Ren P, Li Y, Peng B, Dai L, Lei N,
Yao W, Zhao G, Li L and Zhang J: Autoantibodies against
glucose-regulated protein 78 as serological diagnostic biomarkers
in hepatocellular carcinoma. Int J Oncol. 41:1061–1067.
2012.PubMed/NCBI
|
|
4
|
Wang L, Li B, Li L and Wang T:
MicroRNA-497 suppresses proliferation and induces apoptosis in
prostate cancer cells. Asian Pac J Cancer Prev. 14:3499–3502. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y
and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular
carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer
Res. 69:1135–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saumet A, Vetter G, Bouttier M, Antoine E,
Roubert C, Orsetti B, Theillet C and Lecellier CH: Estrogen and
retinoic acid antagonistically regulate several microRNA genes to
control aerobic glycolysis in breast cancer cells. Mol Biosyst.
8:3242–3253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Varambally S, Cao Q, Mani RS, Shankar S,
Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, et al:
Genomic loss of microRNA-101 leads to overexpression of histone
methyltransferase EZH2 in cancer. Science. 322:1695–1699. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saito A, Suzuki HI, Horie M, Ohshima M,
Morishita Y, Abiko Y and Nagase T: An integrated expression
profiling reveals target genes of TGF-β and TNF-α possibly mediated
by microRNAs in lung cancer cells. PLoS One. 8:e565872013.
View Article : Google Scholar
|
|
9
|
Piepoli A, Tavano F, Copetti M, Mazza T,
Palumbo O, Panza A, di Mola FF, Pazienza V, Mazzoccoli G, Biscaglia
G, et al: Mirna expression profiles identify drivers in colorectal
and pancreatic cancers. PLoS One. 7:e336632012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fulci V, Chiaretti S, Goldoni M, Azzalin
G, Carucci N, Tavolaro S, Castellano L, Magrelli A, Citarella F,
Messina M, et al: Quantitative technologies establish a novel
microRNA profile of chronic lymphocytic leukemia. Blood.
109:4944–4951. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karreth FA, Tay Y, Perna D, Ala U, Tan SM,
Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, et al:
In vivo identification of tumor-suppressive PTEN ceRNAs in an
oncogenic BRAF-induced mouse model of melanoma. Cell. 147:382–395.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SS, Shin HS, Kim HJ, Lee SJ, Lee HS,
Hyun KH, Kim YH, Kwon BW, Han JH, Choi H, et al: Analysis of
prognostic factors and 5-year survival rate in patients with
hepatocellular carcinoma: A single-center experience. Korean J
Hepatol. 18:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ang SF, Tan SH, Toh HC, Poon DY, Ong SY,
Foo KF and Choo SP: Activity of thalidomide and capecitabine in
patients with advanced hepatocellular carcinoma. Am J Clin Oncol.
35:222–227. 2012. View Article : Google Scholar
|
|
15
|
Zhou L, Rui JA, Wang SB, Chen SG and Qu Q:
Risk factors of poor prognosis and portal vein tumor thrombosis
after curative resection of solitary hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 12:68–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Deng ZS, Liao MM, Wang N, Zhang
XQ, Yu HY and Zhang YD: Tumor associated glycoprotein-72 is a novel
marker for poor survival in hepatocellular carcinoma. Pathol Oncol
Res. 18:911–916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang W, Sun T, Cao J, Liu F, Tian Y and
Zhu W: Downregulation of miR-210 expression inhibits proliferation,
induces apoptosis and enhances radiosensitivity in hypoxic human
hepatoma cells in vitro. Exp Cell Res. 318:944–954. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo J, Yao F, Lou Y, Xu C, Xiao B, Zhou W,
Chen J, Hu Y and Liu Z: Detecting carcinoma cells in peripheral
blood of patients with hepatocellular carcinoma by immunomagnetic
beads and rt-PCR. J Clin Gastroenterol. 41:783–788. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng X, Pan C, Diao Y, You Y, Yang C and
Hu Z: Development of microsatellite markers by transcriptome
sequencing in two species of Amorphophallus (Araceae). BMC
Genomics. 14:4902013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia H, Zhao C, Hou L, Li A, Zhao S, Bi Y,
An J, Zhao Y, Wan S and Wang X: Transcriptome profiling of peanut
gynophores revealed global reprogramming of gene expression during
early pod development in darkness. BMC Genomics. 14:5172013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gorur A, Balci Fidanci S, Dogruer Unal N,
Ayaz L, Akbayir S, Yildirim Yaroglu H, Dirlik M, Serin MS and Tamer
L: Determination of plasma microRNA for early detection of gastric
cancer. Mol Biol Rep. 40:2091–2096. 2013. View Article : Google Scholar
|
|
22
|
Burgucu D, Guney K, Sahinturk D, Ozbudak
IH, Ozel D, Ozbilim G and Yavuzer U: Tbx3 represses PTEN and is
over-expressed in head and neck squamous cell carcinoma. BMC
Cancer. 12:4812012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ekizoglu S, Dalay N, Karaman E, Akdeniz D,
Ozaydin A and Buyru N: LKB1 downregulation may be independent of
promoter methylation or FOXO3 expression in head and neck cancer.
Transl Res. 162:122–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Oliveira KB, Guembarovski RL,
Guembarovski AM, da Silva do Amaral Herrera AC, Sobrinho WJ, Ariza
CB and Watanabe MA: CXCL12, CXCR4 and IFNγ genes expression:
Implications for proinflammatory microenvironment of breast cancer.
Clin Exp Med. 13:211–219. 2013. View Article : Google Scholar
|
|
25
|
Tsukamoto K, Ohta N, Shirai Y and Emi M: A
highly polymorphic CA repeat marker at the human interleukin 6
receptor (IL6R) locus. J Hum Genet. 43:289–290. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fulzele A, Malgundkar SA, Govekar RB,
Patil A, Kane SV, Chaturvedi P, D'Cruz AK and Zingde SM: Proteomic
profile of keratins in cancer of the gingivo buccal complex:
Consolidating insights for clinical applications. J Proteomics.
91:242–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dou LP, Li YH, Wang LL and Yu L: HOXA9 is
direct target of miR-196a. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
27:166–169. 2011.In Chinese. PubMed/NCBI
|
|
28
|
Wang YP, Tang XJ, Chen XH, Che GW, Zhu DX,
Sun ZL and Zhou QH: Study on cloning of hTERT promoter and its
targeting transcriptional activities in telomerase-positive lung
cancer cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 37:497–501.
2006.In Chinese. PubMed/NCBI
|
|
29
|
Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J,
Hu B, Li H, Chen S, Zhao H, et al: Metastasis-related miR-185 is a
potential prognostic biomarker for hepatocellular carcinoma in
early stage. Biomed Pharmacother. 67:393–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Katayama Y, Maeda M, Miyaguchi K, Nemoto
S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S and Tanaka H:
Identification of pathogenesis-related microRNAs in hepatocellular
carcinoma by expression profiling. Oncol Lett. 4:817–823.
2012.PubMed/NCBI
|
|
31
|
Kim WH, Min KT, Jeon YJ, Kwon CI, Ko KH,
Park PW, Hong SP, Rim KS, Kwon SW, Hwang SG, et al: Association
study of microRNA polymorphisms with hepatocellular carcinoma in
Korean population. Gene. 504:92–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Furnari FB, Lin H, Huang HS and Cavenee
WK: Growth suppression of glioma cells by PTEN requires a
functional phosphatase catalytic domain. Proc Natl Acad Sci USA.
94:12479–12484. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dahia PL, Marsh DJ, Zheng Z, Zedenius J,
Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, et
al: Somatic deletions and mutations in the Cowden disease gene,
PTEN, in sporadic thyroid tumors. Cancer Res. 57:4710–4713.
1997.PubMed/NCBI
|
|
34
|
Inaba N, Kimura M, Fujioka K, Ikeda K,
Somura H, Akiyoshi K, Inoue Y, Nomura M, Saito Y, Saito H, et al:
The effect of PTEN on proliferation and drug-, and radiosensitivity
in malignant glioma cells. Anticancer Res. 31:1653–1658.
2011.PubMed/NCBI
|
|
35
|
Barbosa M, Henrique M, Pinto-Basto J,
Claes K and Soares G: Prostate cancer in Cowden syndrome: Somatic
loss and germline mutation of the PTEN gene. Cancer Genet.
204:224–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ogita S and Lorusso P: Targeting
phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs. Target
Oncol. 6:103–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karra L, Shushan A, Ben-Meir A, Rojansky
N, Klein BY, Shveiky D, Levitzki R and Ben-Bassat H: Changes
related to phosphatidylinositol 3-kinase/Akt signaling in
leiomyomas: Possible involvement of glycogen synthase kinase 3alpha
and cyclin D2 in the pathophysiology. Fertil Steril. 93:2646–2651.
2010. View Article : Google Scholar
|
|
38
|
Kim HA, Kim KJ, Seo KH, Lee HK and Im SY:
PTEN/MAPK pathways play a key role in platelet-activating
factor-induced experimental pulmonary tumor metastasis. FEBS Lett.
586:4296–4302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mutter GL, Lin MC, Fitzgerald JT, Kum JB,
Baak JP, Lees JA, Weng LP and Eng C: Altered PTEN expression as a
diagnostic marker for the earliest endometrial precancers. J Natl
Cancer Inst. 92:924–930. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Y, Sun Y, Chen L, Xu X, Zhang X, Wang
B, Min L and Liu W: miRNA-200c increases the sensitivity of breast
cancer cells to doxorubicin through the suppression of
E-cadherin-mediated PTEN/Akt signaling. Mol Med Rep. 7:1579–1584.
2013.PubMed/NCBI
|
|
41
|
Xiong X, Ren HZ, Li MH, Mei JH, Wen JF and
Zheng CL: Down-regulated miRNA-214 induces a cell cycle G1 arrest
in gastric cancer cells by up-regulating the PTEN protein. Pathol
Oncol Res. 17:931–937. 2011. View Article : Google Scholar : PubMed/NCBI
|
